Oxidative stress in the pathophysiology of metabolic syndrome: which mechanisms are involved?

Detalhes bibliográficos
Autor(a) principal: Avelar,Thalia M. T.
Data de Publicação: 2015
Outros Autores: Storch,Amanda S., Castro,Luana A., Azevedo,Gabriela V. M. M., Ferraz,Leda, Lopes,Patricia F.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442015000400231
Resumo: ABSTRACTMetabolic syndrome (MS) is a combination of cardiometabolic risk factors, including obesity, hyperglycemia, hypertriglyceridemia, dyslipidemia and hypertension. Several studies report that oxidative condition caused by overproduction of reactive oxygen species (ROS) plays an important role in the development of MS. Our body has natural antioxidant system to reduce oxidative stress, which consists of numerous endogenous and exogenous components and antioxidants enzymes that are able to inactivate ROS. The main antioxidant defense enzymes that contribute to reduce oxidative stress are superoxide dismutase (SOD), catalase (CAT) and gluthatione peroxidase (GPx). The high-density lipoprotein cholesterol (HDL-c) is also associated with oxidative stress because it presents antioxidant and anti-inflammatory properties. HDL-c antioxidant activity may be attributed at least in part, to serum paraoxonase 1 (PON1) activity. Furthermore, derivatives of reactive oxygen metabolites (d-ROMs) also stand out as acting in cardiovascular disease and diabetes, by the imbalance in ROS production, and close relationship with inflammation. Recent reports have indicated the gamma-glutamyl transferase (GGT) as a promising biomarker for diagnosis of MS, because it is related to oxidative stress, since it plays an important role in the metabolism of extracellular glutathione. Based on this, several studies have searched for better markers for oxidative stress involved in development of MS.
id SBP-1_6b227681a143569366e5786a2bcc7fa7
oai_identifier_str oai:scielo:S1676-24442015000400231
network_acronym_str SBP-1
network_name_str Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)
repository_id_str
spelling Oxidative stress in the pathophysiology of metabolic syndrome: which mechanisms are involved?metabolic syndrome Xreactive oxygen speciesantioxidantsHDL cholesterolgamma-glutamyl transferaseABSTRACTMetabolic syndrome (MS) is a combination of cardiometabolic risk factors, including obesity, hyperglycemia, hypertriglyceridemia, dyslipidemia and hypertension. Several studies report that oxidative condition caused by overproduction of reactive oxygen species (ROS) plays an important role in the development of MS. Our body has natural antioxidant system to reduce oxidative stress, which consists of numerous endogenous and exogenous components and antioxidants enzymes that are able to inactivate ROS. The main antioxidant defense enzymes that contribute to reduce oxidative stress are superoxide dismutase (SOD), catalase (CAT) and gluthatione peroxidase (GPx). The high-density lipoprotein cholesterol (HDL-c) is also associated with oxidative stress because it presents antioxidant and anti-inflammatory properties. HDL-c antioxidant activity may be attributed at least in part, to serum paraoxonase 1 (PON1) activity. Furthermore, derivatives of reactive oxygen metabolites (d-ROMs) also stand out as acting in cardiovascular disease and diabetes, by the imbalance in ROS production, and close relationship with inflammation. Recent reports have indicated the gamma-glutamyl transferase (GGT) as a promising biomarker for diagnosis of MS, because it is related to oxidative stress, since it plays an important role in the metabolism of extracellular glutathione. Based on this, several studies have searched for better markers for oxidative stress involved in development of MS.Sociedade Brasileira de Patologia Clínica2015-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442015000400231Jornal Brasileiro de Patologia e Medicina Laboratorial v.51 n.4 2015reponame:Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)instname:Sociedade Brasileira de Patologia (SBP)instacron:SBP10.5935/1676-2444.20150039info:eu-repo/semantics/openAccessAvelar,Thalia M. T.Storch,Amanda S.Castro,Luana A.Azevedo,Gabriela V. M. M.Ferraz,LedaLopes,Patricia F.eng2015-09-11T00:00:00Zoai:scielo:S1676-24442015000400231Revistahttp://www.scielo.br/jbpmlhttps://old.scielo.br/oai/scielo-oai.php||jbpml@sbpc.org.br1678-47741676-2444opendoar:2015-09-11T00:00Jornal Brasileiro de Patologia e Medicina Laboratorial (Online) - Sociedade Brasileira de Patologia (SBP)false
dc.title.none.fl_str_mv Oxidative stress in the pathophysiology of metabolic syndrome: which mechanisms are involved?
title Oxidative stress in the pathophysiology of metabolic syndrome: which mechanisms are involved?
spellingShingle Oxidative stress in the pathophysiology of metabolic syndrome: which mechanisms are involved?
Avelar,Thalia M. T.
metabolic syndrome X
reactive oxygen species
antioxidants
HDL cholesterol
gamma-glutamyl transferase
title_short Oxidative stress in the pathophysiology of metabolic syndrome: which mechanisms are involved?
title_full Oxidative stress in the pathophysiology of metabolic syndrome: which mechanisms are involved?
title_fullStr Oxidative stress in the pathophysiology of metabolic syndrome: which mechanisms are involved?
title_full_unstemmed Oxidative stress in the pathophysiology of metabolic syndrome: which mechanisms are involved?
title_sort Oxidative stress in the pathophysiology of metabolic syndrome: which mechanisms are involved?
author Avelar,Thalia M. T.
author_facet Avelar,Thalia M. T.
Storch,Amanda S.
Castro,Luana A.
Azevedo,Gabriela V. M. M.
Ferraz,Leda
Lopes,Patricia F.
author_role author
author2 Storch,Amanda S.
Castro,Luana A.
Azevedo,Gabriela V. M. M.
Ferraz,Leda
Lopes,Patricia F.
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Avelar,Thalia M. T.
Storch,Amanda S.
Castro,Luana A.
Azevedo,Gabriela V. M. M.
Ferraz,Leda
Lopes,Patricia F.
dc.subject.por.fl_str_mv metabolic syndrome X
reactive oxygen species
antioxidants
HDL cholesterol
gamma-glutamyl transferase
topic metabolic syndrome X
reactive oxygen species
antioxidants
HDL cholesterol
gamma-glutamyl transferase
description ABSTRACTMetabolic syndrome (MS) is a combination of cardiometabolic risk factors, including obesity, hyperglycemia, hypertriglyceridemia, dyslipidemia and hypertension. Several studies report that oxidative condition caused by overproduction of reactive oxygen species (ROS) plays an important role in the development of MS. Our body has natural antioxidant system to reduce oxidative stress, which consists of numerous endogenous and exogenous components and antioxidants enzymes that are able to inactivate ROS. The main antioxidant defense enzymes that contribute to reduce oxidative stress are superoxide dismutase (SOD), catalase (CAT) and gluthatione peroxidase (GPx). The high-density lipoprotein cholesterol (HDL-c) is also associated with oxidative stress because it presents antioxidant and anti-inflammatory properties. HDL-c antioxidant activity may be attributed at least in part, to serum paraoxonase 1 (PON1) activity. Furthermore, derivatives of reactive oxygen metabolites (d-ROMs) also stand out as acting in cardiovascular disease and diabetes, by the imbalance in ROS production, and close relationship with inflammation. Recent reports have indicated the gamma-glutamyl transferase (GGT) as a promising biomarker for diagnosis of MS, because it is related to oxidative stress, since it plays an important role in the metabolism of extracellular glutathione. Based on this, several studies have searched for better markers for oxidative stress involved in development of MS.
publishDate 2015
dc.date.none.fl_str_mv 2015-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442015000400231
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442015000400231
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/1676-2444.20150039
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv
Sociedade Brasileira de Patologia Clínica
publisher.none.fl_str_mv
Sociedade Brasileira de Patologia Clínica
dc.source.none.fl_str_mv Jornal Brasileiro de Patologia e Medicina Laboratorial v.51 n.4 2015
reponame:Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)
instname:Sociedade Brasileira de Patologia (SBP)
instacron:SBP
instname_str Sociedade Brasileira de Patologia (SBP)
instacron_str SBP
institution SBP
reponame_str Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)
collection Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)
repository.name.fl_str_mv Jornal Brasileiro de Patologia e Medicina Laboratorial (Online) - Sociedade Brasileira de Patologia (SBP)
repository.mail.fl_str_mv ||jbpml@sbpc.org.br
_version_ 1752122296306237440